1. Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer
   Sarah-Louise Ryan et al, 2021, Frontiers in Oncology CrossRef
2. Survival and Functional Outcomes after Surgical Treatment for Spinal Metastasis in Patients with a Short Life Expectancy
   Se-Jun Park et al, 2022, Journal of Clinical Medicine CrossRef
3. RASSF1A Enhances Chemosensitivity of NSCLC Cells Through Activating Autophagy by Regulating MAP1S to Inactivate Keap1-Nrf2 Pathway
   Jincai Wang et al, 2021, Drug Design, Development and Therapy CrossRef
4. A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101)
   null null et al, 2018, International Journal of Clinical Oncology CrossRef
5. Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC
   Sarah-Louise Ryan et al, 2019, Lung Cancer CrossRef
6. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3
   Jin Mo Ku et al, 2020, Phytomedicine CrossRef
7. Impact of Targeted Therapy on the Survival of Patients With Advanced-Stage Non-small Cell Lung Cancer in Oncosalud - AUNA
   Alfredo Aguilar et al, 2022, Cancer Control CrossRef